UCB Named Proof-of-Concept Partner for Oxford Genome Sciences New Database, Business Model | GenomeWeb

Oxford Genome Sciences said last week that UCB, a biopharmaceutical firm based in Belgium, has licensed its Oxford Genome Anatomy Project (OGAP) database — the first such deal for OGeS since it launched 18 months ago.

OGeS was founded by several members of Oxford GlycoSciences' proteomics team after Celltech acquired that firm in December 2003. OGeS CEO Christian Rohlff and several of his OGS colleagues acquired a suite of technology, data, and intellectual property that Celltech jettisoned at the time of the OGS acquisition [BioInform 11-24-03].

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.